Stocktoria
Summit Therapeutics Inc. SMMT
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2004-10-14
Summit Therapeutics Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 7,898,585 | $61.6M | 1.02% |
| Point72 Asset Management, L.P. | 3,697,803 | $53.9M | 0.48% |
| CITADEL ADVISORS LLC | 2,875,116 | $41.9M | 0.37% |
| MILLENNIUM MANAGEMENT LLC | 2,349,081 | $34.2M | 0.3% |
| D. E. Shaw & Co., Inc. | 1,243,556 | $18.1M | 0.16% |
| TWO SIGMA INVESTMENTS, LP | 696,714 | $10.2M | 0.09% |
| AQR CAPITAL MANAGEMENT LLC | 542,178 | $7.9M | 0.07% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.